Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample

Psychological Medicine
E J Barkus, S Lewis

Abstract

The relationship between cannabis use and psychosis is still a matter for debate. Accounting for the individual differences in subjective experiences to recreational cannabis use in the general population may hold some clues to the aetiological relationship between cannabis and psychotic symptoms. We hypothesized that schizotypy would account for the individual differences in subjective experiences after cannabis use but not in patterns of use. In a sample of 532 young people who had used cannabis at least once, we examined the relationship between the Cannabis Experiences Questionnaire (CEQ) and the Schizotypal Personality Questionnaire (SPQ). Additionally, we examined the psychometric properties of the CEQ. We replicated our previously reported findings that schizotypy was associated with increased psychosis-like experiences and after-effects, but also found that high-scoring schizotypes reported more pleasurable experiences when smoking cannabis. Using new subscales derived from principal components analysis (PCA), we found that the psychosis-like items were most related to varying rates of schizotypy both during the immediate use of cannabis and in the after-effects of cannabis use. High-scoring schizotypes who used cannabi...Continue Reading

References

Mar 1, 1995·The Australian and New Zealand Journal of Psychiatry·M BaigentR J Hafner
Apr 1, 1994·Archives of General Psychiatry·D H LinszenM E Lenior
Oct 27, 1998·The Journal of Nervous and Mental Disease·A HonigM W deVries
Mar 30, 2001·Schizophrenia Research·P D SkosnikS Park
Feb 19, 2002·Psychiatry Research·Patrick DumasThierry d'Amato
Aug 16, 2002·American Journal of Epidemiology·J van OsH Verdoux
Jun 3, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Deepak Cyril D'SouzaJohn Harrison Krystal
Mar 15, 2005·Drug and Alcohol Review·Wayne HallMaree Teesson
Mar 23, 2005·Biological Psychiatry·Deepak Cyril D'SouzaJohn Harrison Krystal
Apr 6, 2005·Psychiatry Research·Jason SchiffmanJoseph LaBrie
Apr 26, 2005·Addiction·Robert F FerdinandFrank C Verhulst
Oct 4, 2005·Schizophrenia Research·Hélène VerdouxAudrey Cougnard
Dec 2, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Vaibhav A DiwadkarMatcheri S Keshavan
Dec 2, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Mikkel ArendtPovl Munk-Jørgensen
Jan 21, 2006·BMJ : British Medical Journal·David M FergussonJoseph M Boden
Aug 29, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cécile HenquetJim van Os
Sep 6, 2006·Human Psychopharmacology·Mitch Earleywine
Sep 30, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Louisa Degenhardt, Wayne Hall
Jan 19, 2008·The British Journal of Psychiatry. Supplement·Emma BarkusShôn Lewis

❮ Previous
Next ❯

Citations

Jul 18, 2009·European Archives of Psychiatry and Clinical Neuroscience·Deepak Cyril D'SouzaMohini Ranganathan
Aug 30, 2008·Schizophrenia Bulletin·Cécile HenquetRobin M Murray
Mar 3, 2010·Annual Review of Clinical Psychology·Emma Barkus, Robin M Murray
Apr 3, 2012·Harm Reduction Journal·Ariella A CameraLynn E Delisi
Jul 2, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Silvia AlemanyLourdes Fañanás
Dec 6, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Ivan KoychevEmma Barkus
Sep 21, 2010·Journal of Psychiatric Research·Alex S CohenDiana W Stewart
Sep 4, 2010·Psychiatry Research·Daniel J FridbergPatrick D Skosnik
Jul 2, 2010·British Journal of Pharmacology·Daniel T MaloneTiziana Rubino
Aug 28, 2012·Psychiatry Research·Gina M NajoliaAlex S Cohen
Feb 14, 2012·Schizophrenia Research·Deidre M AnglinPatricia R Cohen
Apr 15, 2015·Schizophrenia Research·Lauren Spriggens, Leanne Hides
Aug 16, 2014·Behavioural Brain Research·Ashley Jayne SkilleterThomas Wesley Weickert
Dec 3, 2014·Psychiatry Research·Daniël KleinloogJoop van Gerven
Jan 15, 2013·Neuroscience and Biobehavioral Reviews·M T NelsonL J Phillips
Oct 9, 2012·Journal of Psychopharmacology·Amir EnglundShitij Kapur
Oct 13, 2010·Journal of Psychopharmacology·H R SumnallJ C Cole
Sep 21, 2010·Journal of Psychopharmacology·Emma BarkusRobin M Murray
Apr 16, 2009·International Review of Psychiatry·R Andrew SewellDeepak Cyril D'Souza
Jul 21, 2014·Psychopharmacology·Judith F NottagePaul D Morrison
Oct 21, 2017·Early Intervention in Psychiatry·Michael L BirnbaumMichael T Compton
May 13, 2017·Reviews in the Neurosciences·Ahmed A MoustafaWael Mohamed
Mar 27, 2015·Schizophrenia Bulletin·Oliver J Mason
Jul 3, 2018·The Journal of Nervous and Mental Disease·Francesco BernardiniGwenolé Loas
Nov 3, 2010·Substance Use & Misuse·John Stirling, Lauren McCoy
Sep 30, 2019·European Archives of Psychiatry and Clinical Neuroscience·Alkomiet HasanEva Hoch
Nov 20, 2016·Human Psychopharmacology·Emma BarkusRobin M Murray
Jul 18, 2015·European Archives of Psychiatry and Clinical Neuroscience·Johannes RentzschMaria Christiane Jockers-Scherübl
Apr 23, 2021·Schizophrenia Research·Abigail C WrightDaphne J Holt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.